Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway-Reference-Cited by-同舟云学术

Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway

Published:2021-01 Issue: Volume:81 Page:153437
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Wu Han-Tsang,Lin Joseph,Liu Yi-En,Chen Hsiao-Fan,Hsu Kai-Wen,Lin Shu-Hsuan,Peng Kai-Yen,Lin Kuo-Juei,Hsieh Chang-Chi,Chen Dar-Ren

Funder

Changhua Christian Hospital

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference58 articles.

1. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study;Aleskandarany;Breast Cancer Res. Treat.,2014

2. Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features;Astvatsaturyan;PloS one,2018

3. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells;Attoub;Eur. J. Pharmacol.,2011

4. Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo;Barton;Mo.l Cancer. Ther.,2015

5. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site;Bayer-Garner;Mod. Pathol.,2000

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer;Bioorganic & Medicinal Chemistry;2024-10

2. Network medicine based approach for identifying the type 2 diabetes, osteoarthritis and triple negative breast cancer interactome: Finding the hub of hub genes;Heliyon;2024-09

3. Luteolin exerts anti‐tumour immunity in hepatocellular carcinoma by accelerating CD8⁺ T lymphocyte infiltration;Journal of Cellular and Molecular Medicine;2024-09

4. Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation;Heliyon;2024-09

5. Role of flavonoids in inhibiting triple-negative breast cancer;Frontiers in Pharmacology;2024-08-27